Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

NCT03617432 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Experimental Tumor

Interventions

DRUG: Chidamide
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Etoposide
DRUG: Prednisone

Sponsor

Peking University

Collaborators

[object Object]
[object Object]
[object Object]